Journal of Surgical Oncology · 1999 · 25 citations · 19 references
MedicineOncologyPathologyMetastasisOncogenesTumor ProgressionEndocrine Tumor PathologyHormone-related CarcinogenesisThyroid CancerThyroid EndocrinologyTumor MarkersTumor-associated AntigensDistant Nodal MetastasisFollicular Thyroid NeoplasiaFollicular Thyroid NeoplasmsOccult MalignancyPapillary Thyroid Carcinoma PathologyThyroid AdenomasThyroid Cancer PathologyTyrosine Kinase Receptors
BACKGROUND AND OBJECTIVES: The exact role of ret/PTC in the development of papillary carcinoma remains unclear. Expression of the ret/PTC oncogene was examined immunohistochemically to address its role in the progression of thyroid carcinomas. METHODS: Paraffin-embedded samples from 34 clinically evident thyroid papillary carcinomas and 19 occult papillary carcinomas were analyzed using an antibody raised against the ret tyrosine kinase domain. RESULTS: Expression of ret/PTC was demonstrated in 6/19 (32%) occult carcinomas. The frequency of expression of ret/PTC in clinically evident carcinomas in 16/34 (47%) was significantly higher than in normal tissues (0%) and follicular adenomas (1/14, 7%, P < 0.01).ret/PTC expression was observed more frequently in the peripheral areas of clinically evident carcinomas (P < 0.01). Although there was no correlation of ret/PTC expression with tumor size, lymph node metastasis, or distant metastasis, the incidence of ret/PTC expression in tumors with extrathyroidal invasion (13/19, 68%) was significantly higher than those without extrathyroidal invasion (3/15, 20%, P < 0.01). Local invasion was found in none of the occult carcinomas. The frequency of expression in occult carcinomas was significantly lower than in clinically evident carcinomas with extrathyroidal invasion (P < 0.05). CONCLUSIONS: The ret/PTC oncogene may be involved in the local invasion of thyroid papillary carcinomas.
19
Germ-line mutations of the RET proto-oncogene in multiple endocrine neoplasia type 2A
Lois M. Mulligan, John B. Kwok, Catherine S. Healey et al. · Nature · 1993 · 2K citations
Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC
Helen Donis-Keller, Shenshen Dou, David Chi et al. · Human Molecular Genetics · 1993 · 1.3K citations
Functional receptor for GDNF encoded by the c-ret proto-oncogene
Miles Trupp, Ernest Arenas, Ann-Sofie Nilsson et al. · Nature · 1996 · 800 citations